Crispr-Cas-Based Genome Editing for Treating Human Diseases-Part a: Volume 208
| PUBLISHER | Academic Press (09/12/2024) |
| PRODUCT TYPE | Hardcover (Hardcover) |
Description
CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A, Volume 208 represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems are proven a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. CRISPR-Cas9 system is being used in microbial genome editing, mammalian genome editing, disease models, and more. It has shown potential in human disease treatment. However, it is not easy to find CRISPR-Cas systems genome editing in a single source. This volume offers CRISPR-Cas systems for human diseases, bacterial disease, gut microbiome editing, viral disease, protozoan disease, fungal disease, stem cell therapy, CRISPR in epigenetics, CRISPR in cancer, autoimmune and blood disorders. In addition, it highlights a number of aspects of the CRISPR-Cas systems that can help the basic understanding of students, researchers, clinicians, entrepreneurs, and stakeholders to perform their research with great interest.
Show More
Product Format
Product Details
ISBN-13:
9780443315886
ISBN-10:
0443315884
Binding:
Hardback or Cased Book (Sewn)
Content Language:
English
More Product Details
Page Count:
308
Carton Quantity:
16
Product Dimensions:
6.20 x 1.00 x 9.10 inches
Weight:
1.27 pound(s)
Country of Origin:
US
Subject Information
BISAC Categories
Science | Life Sciences - Biophysics
Science | Life Sciences - Molecular Biology
Descriptions, Reviews, Etc.
publisher marketing
CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A, Volume 208 represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems are proven a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. CRISPR-Cas9 system is being used in microbial genome editing, mammalian genome editing, disease models, and more. It has shown potential in human disease treatment. However, it is not easy to find CRISPR-Cas systems genome editing in a single source. This volume offers CRISPR-Cas systems for human diseases, bacterial disease, gut microbiome editing, viral disease, protozoan disease, fungal disease, stem cell therapy, CRISPR in epigenetics, CRISPR in cancer, autoimmune and blood disorders. In addition, it highlights a number of aspects of the CRISPR-Cas systems that can help the basic understanding of students, researchers, clinicians, entrepreneurs, and stakeholders to perform their research with great interest.
Show More
Your Price
$169.29